| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/25/2007 | CN101002736A Slow-release preparation containing polyheteroside of tripterygium wilfordii |
| 07/25/2007 | CN101002735A Recombination interleukin-2 frozen-dried preparation, and its preparing method |
| 07/25/2007 | CN101002734A Preparation of superfine powder containing anerthol trithione |
| 07/25/2007 | CN101002733A Stable elaioplast composition |
| 07/25/2007 | CN101002732A Germ-free medicinal compsns. |
| 07/25/2007 | CN101002731A Wound-protection liquid, and its preparing method |
| 07/25/2007 | CN101002730A Compounding anticarcinogen containing neovascular-inhibitor |
| 07/25/2007 | CN101002729A Slow released anticarcinogen containing vasoinhibitor |
| 07/25/2007 | CN101002728A Preparation of paclitaxel, and its preparing method |
| 07/25/2007 | CN101002727A Adjuvant for transcutaneous immunization |
| 07/25/2007 | CN101002722A Hydrous gel and production process and use of the hydrous gel |
| 07/25/2007 | CN101002720A Method and apparatus for blowmolding capsules of polyvinylalcohol and blowmolded polyvinylalcohol capsules |
| 07/25/2007 | CA2575395A1 Dispenser for dispensing three or more actives |
| 07/24/2007 | US7247707 Albumin-free factor VIII formulations |
| 07/24/2007 | US7247653 Pharmaceutical composition |
| 07/24/2007 | US7247622 Antibiotic; beta-lactamase inhibitor; therapy for infection |
| 07/24/2007 | US7247620 preventive therapy using nucleic acid coding a protein |
| 07/24/2007 | US7247491 Method for determining release of a peptide from a sustained release polylactide formulation |
| 07/24/2007 | US7247319 Conditioning the quantity of microparticles so that a flowability index of the quantity is greater than about 60 |
| 07/24/2007 | US7247318 Sustained release; therapy for attention deficit disorders |
| 07/24/2007 | US7247317 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) |
| 07/24/2007 | US7247316 Compositions and methods for treating lymphoma |
| 07/24/2007 | US7247315 Compositions and medical device for transdermal delivery of a drug and methods of making and using same |
| 07/24/2007 | US7247313 Polyacrylates coatings for implantable medical devices |
| 07/24/2007 | US7247312 Hydrophobic polymer carrier containing dispersed particles of an active ingredient that is slightly water soluble or insoluble (especially a vaccine), carbonate particles, and particles of a compound that reacts with the carbonate in an aqueous solution to generate CO2, which accelerates release rate |
| 07/24/2007 | US7247154 Method for drug delivery in association with medical or surgical procedures |
| 07/24/2007 | CA2411277C Neurotoxin implant |
| 07/24/2007 | CA2172777C Use of a cgrp antagonist for the treatment of neurogenic skin redness; composition thus produced |
| 07/24/2007 | CA2133995C Method and composition for the treatment of disorders involving immunological dysfunction |
| 07/24/2007 | CA2110491C Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/23/2007 | CA2573472A1 Biodegradable hemostatic compositions |
| 07/19/2007 | WO2007081996A2 Hemostatic textile |
| 07/19/2007 | WO2007081736A1 Osmotic dosage form with controlled release and fast release aspects |
| 07/19/2007 | WO2007081679A2 Medical imaging reference devices |
| 07/19/2007 | WO2007081410A2 Encoded microparticles |
| 07/19/2007 | WO2007081367A1 Dry formulations of aripiprazole |
| 07/19/2007 | WO2007081366A1 Wet granulation pharmaceutical compositions of aripiprazole |
| 07/19/2007 | WO2007081341A1 Controlled release formulation of divalproic acid and its derivatives |
| 07/19/2007 | WO2007080977A1 Preventive or therapeutic agent and method for immune disease |
| 07/19/2007 | WO2007080942A1 ORAL COMPOSITION CONTAINING INTERFERON-α |
| 07/19/2007 | WO2007080902A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 07/19/2007 | WO2007080898A1 Sustained-release hydrogel preparation |
| 07/19/2007 | WO2007080787A1 Coenzyme q10-containing water-soluble compositions |
| 07/19/2007 | WO2007080776A1 Sustained release preparation and method for production thereof |
| 07/19/2007 | WO2007080669A1 Antiviral/antiinflammatory drug composition |
| 07/19/2007 | WO2007080601A1 Stable pharmaceutical formulation of an acid labile compound and process for preparing the same |
| 07/19/2007 | WO2007080509A2 Sustained release compositions of alfuzosin |
| 07/19/2007 | WO2007080263A1 Pharmaceutical composition containing omega-3 fatty acids and a silica |
| 07/19/2007 | WO2007080149A2 Treatment of stressed patients |
| 07/19/2007 | WO2007080074A1 Solid pharmaceutical composition comprising irbesartan |
| 07/19/2007 | WO2007080010A1 Oral s-adenosylmethionine compositions |
| 07/19/2007 | WO2007079758A1 Pellets comprising a core with a water-soluble carrier |
| 07/19/2007 | WO2007061828A3 Pharmaceutical compositions comprising buprenorphine |
| 07/19/2007 | WO2007053647A3 Cosmetic skincare applications employing mineral-derived tubules for controlled release |
| 07/19/2007 | WO2007048219A3 Sustained drug release composition |
| 07/19/2007 | WO2007042961A3 Device for controlled release of chemical molecules |
| 07/19/2007 | WO2007033020A3 Ophthalmic formulation for treatment of dry eye |
| 07/19/2007 | WO2007031345A3 Method for the encapsulation and controlled-release of poorly water-soluble (hydrophobic) liquid and solid active ingredients |
| 07/19/2007 | WO2007031333A3 Improvements in or relating to amphoteric liposomes |
| 07/19/2007 | WO2007014673A3 Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 07/19/2007 | WO2006133835A3 Oral solid pharmaceutical formulation of the tubulin inhibitor indibulin |
| 07/19/2007 | WO2006042751A3 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 07/19/2007 | WO2005120546A3 Compositions and methods for topical diagnostic and therapeutic transport |
| 07/19/2007 | US20070167932 Local concentration management system |
| 07/19/2007 | US20070167502 Association between a heterocyclic compound and an antioxidant agent |
| 07/19/2007 | US20070167402 Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same |
| 07/19/2007 | US20070167389 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 07/19/2007 | US20070167380 Taste masked compositions of erythromycin a and derivatives thereof |
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167368 Dried blood factor composition comprising trehalose |
| 07/19/2007 | US20070167364 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/19/2007 | US20070167359 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 07/19/2007 | US20070167351 Peptide/Lipid Complex Formation by Co-Lyphilization |
| 07/19/2007 | US20070166802 West nile vaccine |
| 07/19/2007 | US20070166388 Combinations and modes of administration of therapeutic agents and combination therapy |
| 07/19/2007 | US20070166387 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate |
| 07/19/2007 | US20070166386 Nanoparticle formation of pharmaceutical ingredients |
| 07/19/2007 | US20070166385 Method of inhibiting restenosis using bisphosphonates |
| 07/19/2007 | US20070166384 Methods , composition and preparations for delivery of immune response modifiers |
| 07/19/2007 | US20070166383 Anionic hydrogel matrices with ph dependent modified release as drug carriers |
| 07/19/2007 | US20070166382 Bioresponsive polymer system for delivery of microbicides |
| 07/19/2007 | US20070166381 Osmotic dosage form with controlled release and fast release aspects |
| 07/19/2007 | US20070166380 Zolpidem tablets |
| 07/19/2007 | US20070166379 Coated tablet containing venlafaxin or its salts with controlled release |
| 07/19/2007 | US20070166378 Oral ribavirin pharmaceutical compositions |
| 07/19/2007 | US20070166377 Water solubility; silicones; vaccines |
| 07/19/2007 | US20070166376 Solid pharmaceutical preparation |
| 07/19/2007 | US20070166375 Modified release oral dosage form using co-polymer of polyvinyl acetate |
| 07/19/2007 | US20070166374 Orally administering edible oil homogenized with an edible wax and stigmasterol, campesterol, beta -sitosterol, chalinosterol, clionasterol, brassicasterol, alpha -spinasterol, daucosterol, desmosterol, and/or poriferasterol; repairing and promoting regeneration of mucosa in gastrointestinal tract |
| 07/19/2007 | US20070166373 Pre-fabricated semi-permeable capsule shells containing a semipermeable layer on a water-dispersible/soluble gelatinous shell for osmotic drug delivery system |
| 07/19/2007 | US20070166372 Preparation of solid coprecipitates of amorphous valsartan |
| 07/19/2007 | US20070166371 Methods of producing films and capsules made from modified carboxymethylcellulose materials |
| 07/19/2007 | US20070166370 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| 07/19/2007 | US20070166369 Photodynamic cosmetic procedure and healing method |
| 07/19/2007 | US20070166368 Protein-Stabilized Liposomal Formulations of Pharmaceutical Agents |
| 07/19/2007 | US20070166367 Adept or gdept producing acetaldehyde |
| 07/19/2007 | US20070166366 Autologous upregulation mechanism allowing optimized cell type-specific and regulated gene expression cells |
| 07/19/2007 | US20070166365 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 07/19/2007 | US20070166364 Transdermal Therapeutic System |